Anti-thrombotic options for secondary prevention in patients with chronic atherosclerotic vascular disease: what does COMPASS add? Academic Article uri icon

Overview

publication date

  • May 7, 2019

Research

keywords

  • Atherosclerosis
  • Fibrinolytic Agents
  • Secondary Prevention
  • Vascular Diseases

Identity

Scopus Document Identifier

  • 85056308238

Digital Object Identifier (DOI)

  • 10.1093/eurheartj/ehy347

PubMed ID

  • 29945212

Additional Document Info

volume

  • 40

issue

  • 18